Analysts expect over 2020 rising revenue Vertex Pharma

For this year Vertex Pharma's revenue will be around 6 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2019's revenue of 4,16 billion USD.

Historical revenues and results Vertex Pharma plus estimates 2020

The analysts expect for 2020 a net profit of 2,5 billion USD. For this year the consensus of the result per share is a profit of 9,8 USD. The price-earnings-ratio equals 21,97.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals a limited 0,31 percent.

Vertex Pharma's market capitalization is based on the number of outstanding shares around 54,93 billion USD. The Vertex Pharma stock was the past 12 months quite volatile. Since last October the stock is even 21 percent higher. This year the stock price moved between 175 and 306 dollar.

Price data Vertex Pharma 2007-2020

Click here for dividend Vertex Pharma. At 15.37 the stock trades 2,28 percent higher at 215,28 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.